Records containing: Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2013-11-27
Impact of Intervention With Deferasirox on the Immune Function of Patients With Hematologic Diseases and Transfusion-Related Iron Overload
CLINICAL_TRIALS study record update · 2013-06-06
A Phase I Trial Of Rituximab And Interleukin-2
CLINICAL_TRIALS study record update · 2013-01-10
A Phase 1 Study of R-(-)-Gossypol (Ascenta's AT-101) in Combination With Paclitaxel and Carboplatin in Solid Tumors
CLINICAL_TRIALS study record update · 2013-01-09
Dose Finding Study of IDEC-Y2B8 With Autologous Stem Cell Support
CLINICAL_TRIALS study record update · 2013-01-07
Standard Dose Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) and Rituximab, or Rituximab and G3139 Phosphorothioate Oligonucleotide (BCL-2 Antisense - NSC-683428) Therapy for Young Patients (< Age 60) With Advanced Stage Diffuse Large B-Cell NHL of Low and Low-Intermediate IPI Risk
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2012-12-19
Phase II Trial of Standard Dose Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) and Rituximab Plus Bevacizumab for Advanced Stage Diffuse Large B-Cell NHL
CLINICAL_TRIALS study record update · 2012-07-09
Pilot Study of Mechanical Stimulation for Prevention of Hematopoietic Cell Transplant Associated Bone Density Loss
CLINICAL_TRIALS study record update · 2012-03-07
INSPIRE: An Internet-based RCT for Long-term Survivors of Hematopoietic Stem Cell Transplantation